Brief: Epigenomics AG Chief Executive Officer Greg Hamilton Resigns
12/04/2023 19:50
April 12 (Reuters) - Epigenomics Ag ECX1k.DE :
* EQS-NEWS: EPIGENOMICS AG: CHIEF EXECUTIVE OFFICER GREG
HAMILTON
RESIGNS
* EPIGENOMICS - CEO GREG HAMILTON, AND CO'S SUPERVISORY
BOARD
AGREED ON HIS RESIGNATION FROM CO AND EXECUTIVE BOARD EFFECTIVE
JUNE 30, 2023
* EPIGENOMICS - BETWEEN NOW AND RESIGNATION DATE HAMILTON
WILL
CONTINUE TO LEAD CO'S RESTRUCTURING EFFORTS IN COORDINATION WITH
SUPERVISORY BOARD
* COMPANY IS COMMITTED TO MAXIMIZING VALUE OF ITS TECHNOLOGY
THROUGH CORPORATE PARTNERING, LICENSING AND/OR ASSET SALES
* TALKS ARE BEING INITIATED WITH OTHER MEMBERS OF EXECUTIVE
BOARD
REGARDING FUTURE COMPOSITION OF BOARD
Source text for Eikon: ID:nEQ5gg2G3a
Further company coverage: ECX1k.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns